Arizona State Retirement System Aerie Pharmaceuticals Inc Transaction History

Arizona State Retirement System

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$6.37 - $15.23 $566 - $1,355	89 Added 0.75%	11,892 $180,000
Q2 2022 Jul 28, 2022	SELL	$4.95 - $9.16 $1,772 - $3,279	-358 Reduced 2.94%	11,803 $89,000
Q1 2022 May 04, 2022	BUY	$5.64 - $9.8 $473 - $823	84 Added 0.7%	12,161 $111,000
Q4 2021 Feb 04, 2022	SELL	$7.02 - $13.33 $407 - $773	-58 Reduced 0.48%	12,077 $85,000
Q3 2021 Nov 12, 2021	BUY	$11.32 - $16.63 $520 - $764	46 Added 0.38%	12,135 $138,000

Q2 2021 Aug 02, 2021	BUY	$15.16 - $18.97 $7,655 - $9,579	505 Added 4.36%	12,089 $194,000
Q1 2021 May 06, 2021	BUY	$13.12 - $20.9 $1,521 - $2,424	116 Added 1.01%	11,584 $207,000
Q4 2020 Jan 28, 2021	SELL	$9.12 - $14.49 $4,104 - $6,520	-450 Reduced 3.78%	11,468 $155,000
Q3 2020 Nov 05, 2020	BUY	$10.46 - $14.46 $124,662 - $172,334	11,918 New	11,918 $140,000
Q2 2020 Aug 04, 2020	SELL	$12.0 - $16.13 $123,972 - $166,639	-10,331 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$11.84 - $25.52 $122,319 - $263,647	10,331 New	10,331 $139,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.